Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DR26FCRH0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,980
Award facts
- Contract value 100% obligated
- $13,979.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,979.52 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 ml auto-injectors on November 5, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 28, 2025, requires delivery to Park Ridge, Illinois, and was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the sole awardee with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499.999 billion through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide Department of Defense military healthcare facilities worldwide with a comprehensive range of pharmaceutical products and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical products including biologics, specialty medications, and routine pharmaceuticals demonstrates its capability to fulfill the specialized medical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCRH0?
SPE2DR26FCRH0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FCRH0 worth?
The government has obligated $13,980 on SPE2DR26FCRH0.
Is contract SPE2DR26FCRH0 an order under another contract?
Yes. SPE2DR26FCRH0 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRH0 competed?
The extent of competition for SPE2DR26FCRH0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award